Newsroom

Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod Capsules, 0.5 Mg

20 Mar 2017 | Read More

Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304

8 Mar 2017 | Read More

Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing®

2 Mar 2017 | Read More

Glenmark’s consolidated revenue increases by 42.55 % to Rs. 25,350.08 Mn for Q3 FY 2016 – 17

2 Feb 2017 | Read More

Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT™ Phase I Trial

3 Jan 2017 | Read More

Library

Profile – Chairman and Managing Director
+
Profile – Chairman and Managing Director
With the idea of creating something unique, Glenn Saldanha took over the reins of the company and helped transform it into a global enterprise worth USD 1.1 billion with offices across 20 countries. Download Profile
Profile – Glenmark Pharmaceuticals
+
Profile – Glenmark Pharmaceuticals
Research-driven, global and integrated pharmaceutical company which is driven to meet unmet medical needs and help pave a new way for a new world. Download Profile

For any media related queries, please email corpcomm@glenmarkpharma.com